With 1.26 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.78 million shares. The 52-week range on HCC shows that it touched its highest point at $75.53 and its lowest point at $45.94 during that stretch. It currently has a 1-year price target of $72.00. With its current market cap of 2.47 billion, HCC has annualized dividend of $0.32 while the current yield stands at 0.68%. Beta for the stock currently stands at 0.82.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HCC was down-trending over the past week, with a drop of -1.69%, but this was down by -11.61% over a month. Three-month performance dropped to -30.19% while six-month performance fell -12.40%. The stock lost -21.67% in the past year, while it has lost -13.26% so far this year. A look at the trailing 12-month EPS for HCC yields 4.79 with Next year EPS estimates of 6.59. For the next quarter, that number is 0.52. This implies an EPS growth rate of -11.30% for this year and 51.10% for next year. EPS is expected to grow by 7.97% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -3.96%.
Float and Shares Shorts:
At present, 52.31 million HCC shares are outstanding with a float of 51.25 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HCC since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $5.87391 being high and $4.86945 being low. For HCC, this leads to a yearly average estimate of $5.26488. Based on analyst estimates, the high estimate for the next quarter is $0.85 and the low estimate is $0.18. The average estimate for the next quarter is thus $0.57.
